A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General Letitia James for allegedly selling the contract drug manufacturer’s stock while knowing about contamination problems at a Baltimore plant that made COVID-19 vaccines.
Sign up here.
The sales ended shortly before Emergent’s share price began declining as concerns mounted about the plant, where vaccine production was halted in April 2021 because of contamination.
Emergent, based in Gaithersburg, Maryland, agreed to … [1411 chars]
Source: Reuters | Published: 2026-01-15T18:15:15Z
Credit: Reuters
